HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massimo D'Apuzzo Selected Research

Massimo D'Apuzzo Research Topics

Disease

19Neoplasms (Cancer)
01/2022 - 12/2009
11Glioma (Gliomas)
01/2022 - 12/2009
6Glioblastoma (Glioblastoma Multiforme)
01/2022 - 04/2012
3Brain Neoplasms (Brain Tumor)
01/2018 - 10/2013
3Prostatic Neoplasms (Prostate Cancer)
01/2017 - 07/2015
2Infections
01/2016 - 12/2014
2Adenocarcinoma
09/2015 - 01/2004
2Carcinogenesis
05/2013 - 08/2005
1Colitis
01/2022
1Disease Progression
01/2022
1Necrosis
01/2022
1Carcinoma (Carcinomatosis)
01/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2019
1Metaplasia
01/2019
1Medulloblastoma
01/2016
1Encephalitis (Encephalitis, Rasmussen)
09/2015
1Breast Neoplasms (Breast Cancer)
12/2014
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2013
1Parathyroid Neoplasms (Parathyroid Neoplasm)
08/2008
1Endometrial Hyperplasia
01/2004
1Endometrial Neoplasms (Endometrial Cancer)
01/2004

Drug/Important Bio-Agent (IBA)

5Chimeric Antigen ReceptorsIBA
01/2022 - 09/2015
4AntigensIBA
01/2022 - 12/2009
4CytokinesIBA
01/2017 - 12/2009
3Cytosine DeaminaseIBA
01/2021 - 05/2013
3Flucytosine (Ancobon)FDA Link
01/2021 - 05/2013
3Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 05/2013
3EnzymesIBA
01/2018 - 05/2013
3ProdrugsIBA
01/2018 - 05/2013
2Hyaluronic Acid (Hyaluronan)IBA
01/2019 - 09/2015
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2018 - 05/2013
2Proteins (Proteins, Gene)FDA Link
01/2016 - 01/2004
2Interleukin-13IBA
09/2015 - 04/2012
1SteroidsIBA
01/2022
1pembrolizumabIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1aldesleukin (Proleukin)FDA Link
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2018
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018
1Pharmaceutical PreparationsIBA
06/2017
1compound 21IBA
06/2017
1Toll-Like Receptor 9IBA
01/2017
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2017
1OligonucleotidesIBA
01/2017
1Tetracycline (Achromycin)FDA LinkGeneric
01/2017
1Interleukin-13 Receptors (Interleukin 13 Receptor)IBA
12/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2016
1LuciferasesIBA
01/2016
1Tva receptorIBA
01/2016
1ArginaseIBA
01/2016
1PEGPH20IBA
09/2015
1Serine Proteases (Serine Protease)IBA
09/2015
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
09/2015
1Granzymes (Granzyme)IBA
08/2015
1Small Interfering RNA (siRNA)IBA
07/2015
1Toll-Like Receptors (Toll-Like Receptor)IBA
07/2015
1AndrogensIBA
07/2015
1pertuzumabIBA
12/2014
1Trastuzumab (Herceptin)FDA Link
12/2014
1Ferrosoferric Oxide (Magnetite)FDA Link
10/2013
1Tyrosine Kinase InhibitorsIBA
05/2013
1bafetinibIBA
05/2013
1Imatinib Mesylate (Gleevec)FDA Link
01/2013
1PerforinIBA
12/2009
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2009
1Dimenhydrinate (DMH)FDA LinkGeneric
08/2005
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2004
1Estrogens (Estrogen)FDA Link
01/2004
1Messenger RNA (mRNA)IBA
01/2004

Therapy/Procedure

15Therapeutics
01/2022 - 12/2009
5Drug Therapy (Chemotherapy)
01/2021 - 12/2009
4Immunotherapy
01/2022 - 08/2015
3Radiotherapy
01/2022 - 12/2009
2Transplantation
07/2015 - 10/2013
1Catheters
01/2019
1Intravenous Administration
01/2018
1Intraventricular Infusions
01/2018
1Castration
08/2015
1Treatment Delay
12/2014
1Intravenous Injections
10/2013
1Radiofrequency Ablation
08/2008
1Injections
08/2005